Purpose: Image-based prediction of coronavirus disease 2019 (COVID-19) severity and resource needs can be an important means to address the COVID-19 pandemic. In this study, we propose an artificial intelligence/machine learning (AI/ML) COVID-19 prognosis method to predict patients' needs for intensive care by analyzing chest X-ray radiography (CXR) images using deep learning.
Approach: The dataset consisted of 8357 CXR exams from 5046 COVID-19-positive patients as confirmed by reverse transcription polymerase chain reaction (RT-PCR) tests for the SARS-CoV-2 virus with a training/validation/test split of 64%/16%/20% on a by patient level. Our model involved a DenseNet121 network with a sequential transfer learning technique employed to train on a sequence of gradually more specific and complex tasks: (1) fine-tuning a model pretrained on ImageNet using a previously established CXR dataset with a broad spectrum of pathologies; (2) refining on another established dataset to detect pneumonia; and (3) fine-tuning using our in-house training/validation datasets to predict patients' needs for intensive care within 24, 48, 72, and 96 h following the CXR exams. The classification performances were evaluated on our independent test set (CXR exams of 1048 patients) using the area under the receiver operating characteristic curve (AUC) as the figure of merit in the task of distinguishing between those COVID-19-positive patients who required intensive care following the imaging exam and those who did not.
Results: Our proposed AI/ML model achieved an AUC (95% confidence interval) of 0.78 (0.74, 0.81) when predicting the need for intensive care 24 h in advance, and at least 0.76 (0.73, 0.80) for 48 h or more in advance using predictions based on the AI prognostic marker derived from CXR images.
Conclusions: This AI/ML prediction model for patients' needs for intensive care has the potential to support both clinical decision-making and resource management.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440543 | PMC |
http://dx.doi.org/10.1117/1.JMI.10.4.044504 | DOI Listing |
Perioper Med (Lond)
January 2025
Department of Anesthesia, Characteristic Medical Center of Chinese People's Armed Police Force (PAP), Tianjin, China.
Background: We investigated the consistency and accuracy of the Index of Consciousness (IoC) and the Bispectral Index (BIS) in monitoring the sedative effect of ciprofol during the induction of general anesthesia. There is extensive literature that reports good consistency and correlations between the IoC1 and the BIS in reflecting the sedation levels induced by propofol and sevoflurane but not by ciprofol.
Objective: The aim was to compare the consistency and accuracy of the IoC and BIS in monitoring the sedative effect of ciprofol during the induction of general anesthesia.
Res Involv Engagem
January 2025
Department of Public Health, Faculty of Health, Aarhus University, Aarhus, Denmark.
Background: Involving parents in decisions about the care of their infant is common practice in most neonatal intensive care units. However, involvement is less common in neonatal research and a gap appears to exist in understanding the process of patient and public involvement. The aim of this study was to explore parents and researchers' experiences of patient and public involvement in a neonatal research project.
View Article and Find Full Text PDFCardiovasc Diabetol
January 2025
Department of Neurology, the First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Background: Triglyceride glucose index(TyG) and a body shape index(ABSI) are both independent predictor of stroke incidence or adverse prognosis but these two indicators seldom were combined to predict. The purpose of this study is to evaluate whether the combination of TyG and ABSI better predict the incidence of stroke.
Methods: Based on the China Health and Retirement Longitudinal Study(CHARLS), 8,257 people aged 45 years and older without stroke were enrolled and followed up to 9 years.
Orphanet J Rare Dis
January 2025
Division of Pediatric Epileptology, Department of Pediatrics I, Medical Faculty of Heidelberg, Heidelberg University, Heidelberg, Germany.
Background: Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder affecting multiple organ systems, with a prevalence of 1:6,760-1:13,520 live births in Germany. On the molecular level, TSC is caused by heterozygous loss-of-function variants in either of the genes TSC1 or TSC2, encoding the Tuberin-Hamartin complex, which acts as a critical upstream suppressor of the mammalian target of rapamycin (mTOR), a key signaling pathway controlling cellular growth and metabolism. Despite the therapeutic success of mTOR inhibition in treating TSC-associated manifestations, studies with mTOR inhibitors in children with TSC above two years of age have failed to demonstrate beneficial effects on disease-related neuropsychological deficits.
View Article and Find Full Text PDFBMC Pharmacol Toxicol
January 2025
Department of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
Background: In patients with sepsis, platelets are activated and adhere to neutrophils, forming platelet-leukocyte aggregates (PLAs) that lead to the development of MODS. ARDS is one of the main manifestations of septic MODS. We designed this study to explore the effects of different anti-plate therapy drugs on platelet activation and platelet-leukocyte aggregate (PLA) formation in the early stage of septic ARDS.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!